Alkermes Awarded 2022 Platinum Bell Seal for Workplace Mental Health

May 19, 2022 10:30 AM ET
Multimedia with summary

We’re proud to announce that we’ve received the 2022 Bell Seal for Workplace Mental Health at Platinum from Mental Health America! This recognition demonstrates our firm commitment to fostering a mentally healthy workplace for all our employees. Learn more: https://bit.ly/3kLe6oQ

About Alkermes
Alkermes plc is a fully-integrated, global biopharmaceutical company developing innovative medicines in the fields of neuroscience and oncology. The company has a portfolio of proprietary commercial products focused on alcohol dependence, opioid dependence, schizophrenia and bipolar I disorder, and a pipeline of product candidates in development for neurodegenerative disorders and cancer. Headquartered in Dublin, Ireland, Alkermes plc has an R&D center in Waltham, Massachusetts; a research and manufacturing facility in Athlone, Ireland; and a manufacturing facility in Wilmington, Ohio. For more information, please visit Alkermes' website at www.alkermes.com.